PATENT CLAIM ANALYSIS

Application Number: 15887105
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "171000"]

Abstract:
A composition of furosemide, or a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof is combined with a steroid, or a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof, to provide a topical medication for nasal or pulmonary treatment. The composition can provide, in a single administration or dosing regime, the anti-inflammatory properties of the steroid and the anti-inflammatory properties of furosemide, without any significant interference between the two, or adverse reaction in situ.

Claim (Index 2):
The pharmaceutical composition according to  claim 1 , wherein the composition is in the form of a formulation selected from the group consisting of nasal drops, eye drops, nasal sprays, nasal inhalation solutions, aerosol powders, nasal insufflation powders, pulmonary inhalation solutions, pulmonary aerosols and pulmonary insufflation powders.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.85417
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12879515', '13644127', '13644126', '12508388', '12508393']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.802463002675285
- 35 USC 102 Novelty (BERT): 0.4804977150149636
- Combined Prediction Score: 0.770266473909253
- Mean Citation Score: 237.137514
- Max Citation Score: 239.27019
- Similarity Product: 206.4240085207593

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test